- Previous close:
- Day's range:
- $0.27 - $0.29
- Year's range:
- $0.25 - $1.18
- Net Income per Share:
- Price-to-Earnings ratio:
- 52-week Price Range:
- Average volume:
Company profile for Asensus Surgical, Inc.
Asensus Surgical, Inc. is a medical device company that is dedicated to Research & Development, Production, and Sale of medical device robotics to enhance minimally invasive surgery (MIS). Through their Senhance Surgical System, they are bringing a revolution in the field of surgical robotics. The Senhance Surgical System is a multi-port robotic surgery system which allows a surgeon to control upto four robotic instruments and a camera for laparoscopic procedures. It is designed to facilitate careful, precise stitching and tissue manipulation in the abdominal and thoracic cavities.
In addition to the Senhance Surgical System, Asensus also offers a range of other instruments, accessories and products such as 3mm diameter instruments, 3mm and 5mm hooks, articulating instruments and the Senhance ultrasonic system. The Senhance Ultrasonic System is an advanced energy device to deliver controlled energy to ligate and divide tissue.
Asensus has built up a strong foundation in the surgical robotic industry and its products are currently used in the United States, Europe, and Asia. The company has seen rapid growth and expansion in the last few years and is moving towards a model of global leadership. Asensus also has a strong research and development department and is continuously innovating to stay ahead of its competition.
The company was founded in 2006 and has its headquarters in Durham, North Carolina. In February 2021, the company changed its name from TransEnterix, Inc. to Asensus Surgical, Inc. Asensus is committed to providing a wide range of innovative products and services to the medical industry. Going forward, the company is looking to expand its operations to new markets and create a larger global footprint. The company also has a strong focus on bringing more advanced robotic technology to the forefront as it works to help surgeons achieve consistently superior outcomes and a new standard of surgery.